Health & Wellness

WHO issues warning on Indian cough syrup linked to 66 Gambian child deaths

The World Health Organization (WHO) has warned that a deadly batch of cough mixture connected to the deaths of dozens of children in Gambia may have been distributed to other countries.

The agency on Wednesday placed a medical product alert on cough and cold syrups made by India’s Maiden Pharmaceuticals Ltd., which have been potentially linked to acute kidney injuries and 66 deaths among children in the tiny West African nation, WHO Director General Tedros Adhanom Ghebreyesus said during a media briefing.

Four contaminated Maiden products were found in a laboratory analysis to contain “unacceptable amounts of diethylene glycol and ethylene glycol,” the WHO said. Tedros added that the global health body is conducting further investigations with the company and Indian regulators, while recommending countries remove the treatments from circulation.

“The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. WHO is conducting further investigation with the company and regulatory authorities in India”-@DrTedros https://t.co/PceTWc836t  – World Health Organization (WHO) (@WHO) October 5, 2022

Calls to the drugmaker’s corporate office in New Delhi weren’t answered and the company, along with India’s medical regulator – the Central Drugs Standard Control Organization – didn’t immediately respond to emails seeking comment.

The deaths shine a spotlight on India’s $42 billion drug making industry, which has been heavily promoted by Prime Minister Narendra Modi as the pharmacy of the world.

India supplies many of the cheap, generic drugs sold in American pharmacies and hundreds of countries globally. But treatments produced in the South Asian nation have been the source of multiple manufacturing scandals in recent years, including the export of tainted heart pills.

Closely-held Maiden Pharma has been making and supplying medical products for more than 30 years and has a presence across multiple countries in Africa, Asia, Eastern Europe, the Middle East, and Russia, according to its website.

Kester Kenn Klomegah

MD Africa Editor Kester Kenn Klomegah is an independent researcher and writer on African affairs in the EurAsian region and former Soviet republics. He wrote previously for African Press Agency, African Executive and Inter Press Service. Earlier, he had worked for The Moscow Times, a reputable English newspaper. Klomegah taught part-time at the Moscow Institute of Modern Journalism. He studied international journalism and mass communication, and later spent a year at the Moscow State Institute of International Relations. He co-authored a book “AIDS/HIV and Men: Taking Risk or Taking Responsibility” published by the London-based Panos Institute. In 2004 and again in 2009, he won the Golden Word Prize for a series of analytical articles on Russia's economic cooperation with African countries.

Recent Posts

The High Percentage of Informal Employment in Indonesia: Causes and Implications

In most developing countries, the informal economy accounts for a large portion of the national…

2 hours ago

China’s Inclusive Diplomacy for Global Cooperation

President Xi Jinping's address at the recently held 2023 CIFTIS resonates as a powerful call…

4 hours ago

U.S. Sanctions and Russia’s Weapon Systems: A New Game in the Quest of High-Tech Microchip

Modern warfare places a great deal of emphasis on semiconductors and microchips because they are…

6 hours ago

The Solution to Ending the War in Ukraine Lies in the Ability to Get the Other Side’s Point of View 

This is so simple, so obvious, that anyone ought to see the truth of it…

9 hours ago

How is Iran’s growing paranoia affect its relations with Azerbaijan?

After the collapse of the Soviet Union, the former Soviet republics tried to search for…

13 hours ago

Exploring Italy by train

Even if the 2023 summer tourist season has been somehow penalised by high prices, Italy…

16 hours ago